0.9601
0.21%
0.002
アフターアワーズ:
1.00
0.0399
+4.16%
前日終値:
$0.9581
開ける:
$0.95
24時間の取引高:
26,414
Relative Volume:
0.13
時価総額:
$2.37M
収益:
-
当期純損益:
$-4.14M
株価収益率:
-0.1324
EPS:
-7.2511
ネットキャッシュフロー:
$-4.79M
1週間 パフォーマンス:
-5.87%
1か月 パフォーマンス:
-8.56%
6か月 パフォーマンス:
-15.78%
1年 パフォーマンス:
-73.40%
Bone Biologics Corp Stock (BBLG) Company Profile
名前
Bone Biologics Corp
セクター
電話
(781) 552-4452
住所
2 BURLINGTON WOODS DRIVE,, BURLINGTON
BBLG を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.9601 | 2.37M | 0 | -4.14M | -4.79M | -7.2511 |
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Bone Biologics Corp (BBLG) 最新ニュース
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Head to Head Contrast: Bone Biologics (NASDAQ:BBLG) vs. Establishment Labs (NASDAQ:ESTA) - Defense World
Orthobiologics Devices And Equipment Market Size, Growth, Trends And Forecast To 2033 - openPR
Orthobiologics Market Overall Study Report 2024-2031 | Zimmer - openPR
Bone Biologics updates ATM offering agreement terms By Investing.com - Investing.com Australia
Bone Biologics updates ATM offering agreement terms - Investing.com
Orthobiologics Devices And Equipment Market In-Depth Analysis of the Research Report 2024-2033: Opportuniti... - WhaTech
Orthobiologics Market Growth in Future Scope 2024-2031 | - openPR
(BBLGW) Proactive Strategies - Stock Traders Daily
Bone Biologics Corp (BBLGW) Quarterly 10-Q Report - Quartzy
Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research - OrthoSpineNews
Orthobiologics Market Is Expected To Reach a Revenue Of USD - GlobeNewswire
Learn to Evaluate (BBLGW) using the Charts - Stock Traders Daily
OFIX INVESTORS: OrthoFix Medical Inc. Stockholders Should Contact Robbins LLP About Joining the Pending OFIX Class Action - The Malaysian Reserve
Theradaptive Announces Peer-Reviewed Publication in Spine of Preclinical Spinal Fusion Study of OsteoAdapt™ SP - OrthoSpineNews
Bone Growth Products Market Insights Report, 2024-2029: - GlobeNewswire
Long Term Trading Analysis for (BBLGW) - Stock Traders Daily
Orthobiologics Global Market Analysis, Trends, Growth, Research And Forecast 2033 - openPR
Spine Biologics Market Report 2024Spine Biologics Market Trends And Share - openPR
BBLGBone Biologics Corp Latest Stock News & Market Updates - StockTitan
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - StockTitan
Therealreal Inc (REAL) Recovers 161.90% From Low: Sitting In The Catbird Seat? - Stocks Register
Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution
BBLG’s 2023 Market Dance: Down -67.26% – Time to Invest? - The InvestChronicle
Stock Market Recap: Bone Biologics Corp (BBLG) Concludes at 1.48, a -6.92 Surge/Decline - The Dwinnex
Tetrous®Inc. Announces Issue of an Additional U.S. Patent Related to EnFix® Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures - OrthoSpineNews
TETROUS®, INC. ANNOUNCES ISSUE OF AN ADDITIONAL U.S. PATENT RELATED TO ENFIX® DEMINERALIZED BONE FIBER IMPLANTS FOR SPORTS MEDICINE SURGICAL PROCEDURES - PR Newswire
Spain Orthobiologics Market Outlook and Forecast to 2033Orthobiologics, Cartilage Repair and Others - GlobalData
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation - OrthoSpineNews
Ortho Biological Products Market Giants Spending Is Going to Boom - Bacterial Vaccines Market with ...
Bone Biologics announces director resignation - Investing.com India
Bone Biologics announces director resignation By Investing.com - Investing.com South Africa
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Bone Void Fillers Market 2024By Industry Outlook, Future Trends, Growth Analysis And Forecast To 2033 - openPR
Was there any good news for Bone Biologics Corp (BBLG) stock in the last session? - US Post News
Bone Biologics Corp (BBLG) Stock: Navigating a Year of Volatility - The InvestChronicle
Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients - Benzinga
In the Green: Bone Biologics Corp (BBLG) Closes at 1.52, Up/Down -26.92 from Previous Day - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges - GuruFocus.com
Orthobiologics Market Industry Analysis 2024 Future Scope, - openPR
A closer look at BBLG’s price-to-free cash flow ratio - US Post News
Bone Biologics Corp (BBLG) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Wall Street today: US stocks surge stops as investors pause after big US Fed rate cut, Nike gains 6.59% | Stock Market News - Mint
Bone Biologics Corp (BBLG) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):